Enrique Grande, One Oncology Madrid Program Director at Quironsalud, shared on X:
“Urothelial carcinoma in Lynch syndrome:
German registry of 3,274 carriers (JCO Precision Oncology). 4.4% developed UC, frequently in the upper tract, and UC was the first malignancy in about one third of affected patients.
MSH2/EPCAM carrier status was associated with higher UC risk (HR 4.43).
Retrospective data: findings support prospective evaluation of genotype-adapted surveillance.”
Title: Urothelial Carcinoma in Lynch Syndrome: Clinical and Molecular Insights From a Large Multicenter Cohort
Authors: Antonia Schuler, Christoph Engel, Aysel Ahadova, Katrin van Beekum, Stefan Aretz, Guido Fechner, Niklas Klümper, Nina Nelius, Emin Gashi, Hugo Montemont, Deepak B. Vangala, Diana Le Duc, Silke Redler, Andreas Block, Tim Ripperger, Alexander Link, Elke Holinski-Feder, Verena Steinke-Lange, Christopher Schroeder, Reiner Siebert, Jacob Nattermann, Matthias Kloor, Robert Hüneburg
You can also read: